Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Establishment Labs Holdings Inc. (ESTA : NSDQ)

• Company Description    Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. Number of Employees: 1,004

• Price / Volume Information    Yesterday's Closing Price: $72.19 Daily Weekly Monthly 20 Day Moving Average: 530,981 shares Shares Outstanding: 29.43 (millions) Market Capitalization: $2,124.55 (millions) Beta: 1.12 52 Week High: $83.31 52 Week Low: $33.35 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.86% 5.44% 12 Week -6.43% -13.50% Year To Date -0.95% -10.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11401 Century Oaks Terrace Suite 400 - Austin,TX 78758 USA ph: 800-924-5072 fax: - ir@establishmentlabs.com http://www.establishmentlabs.com

• General Corporate Information    Officers Filippo Peter Caldini - Chief Executive Officer and Director Nicholas Lewin - Chairman Rajbir S. Denhoy - Chief Financial Officer Juan Jose Chacon Quiros - Director Ann Custin - Director Peer Information Establishment Labs Holdings Inc. (CHCR) Establishment Labs Holdings Inc. (ESRX) Establishment Labs Holdings Inc. (MYDP) Establishment Labs Holdings Inc. (COR) Establishment Labs Holdings Inc. (GBCS) Establishment Labs Holdings Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: G31249108 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 29.43 Most Recent Split Date: (:1) Beta: 1.12 Market Capitalization: $2,124.55 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.22 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.07 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 143.72 Price/Cash Flow: - Price / Sales: 9.25 EPS Growth vs. Year Ago Period: 42.86% vs. Previous Quarter: -344.44% Sales Growth vs. Year Ago Period: 44.71% vs. Previous Quarter: -7.34% ROE 03/31/26 - -218.77 12/31/25 - -201.79 09/30/25 - -235.45 ROA 03/31/26 - -12.31 12/31/25 - -15.03 09/30/25 - -22.83 Current Ratio 03/31/26 - 2.96 12/31/25 - 3.04 09/30/25 - 3.33 Quick Ratio 03/31/26 - 1.91 12/31/25 - 2.00 09/30/25 - 2.10 Operating Margin 03/31/26 - -18.45 12/31/25 - -24.19 09/30/25 - -40.31 Net Margin 03/31/26 - -19.05 12/31/25 - -24.19 09/30/25 - -43.45 Pre-Tax Margin 03/31/26 - -22.35 12/31/25 - -27.49 09/30/25 - -42.96 Book Value 03/31/26 - 0.50 12/31/25 - 0.81 09/30/25 - 0.56 Inventory Turnover 03/31/26 - 0.77 12/31/25 - 0.72 09/30/25 - 0.68 Debt-to-Equity 03/31/26 - 16.82 12/31/25 - 10.51 09/30/25 - 15.06 Debt-to-Capital 03/31/26 - 94.39 12/31/25 - 91.31 09/30/25 - 93.77

Powered by Zacks Investment Research ©